OXiGENE Announces First Quarter 2008 Earnings Conference Call and Webcast
April 28, 2008 09:00 ET
|
Mateon Therapeutics
WALTHAM, Mass., April 28, 2008 (PRIME NEWSWIRE) -- OXiGENE, Inc. (Nasdaq:OXGN) (XSSE:OXGN), a clinical-stage, biopharmaceutical company developing novel therapeutics to treat cancer and eye diseases,...